发明名称 REVERSION OF MALIGNANT PHENOTYPE WITH 9-HYDROXY ELLIPTICINE DERIVATIVES
摘要 The invention relates to the use of 9-hydroxy ellipticine derivatives for the treatment of cancer. 9-hydroxy ellipticine derivatives may prove particularly useful for the treatment of metastatic cancers or cancers escaping conventional cytotoxic chemotherapies.
申请公布号 KR20090023621(A) 申请公布日期 2009.03.05
申请号 KR20087031134 申请日期 2008.12.22
申请人 BIOALLIANCE PHARMA;ECOLE NORMALE SUPERIEURE DE CACHAN;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE(C.N.R.S.) 发明人 AUCLAIR CHRISTIAN;POLARD VALERIE;MAKSIMENKO ANDREI
分类号 C07D471/04;A61K31/475;A61P35/00 主分类号 C07D471/04
代理机构 代理人
主权项
地址